Boswellia Serrata Extract (65% Boswellic Acids)

Botanicalanti-inflammatoryModerate dose evidence

Also known as: Indian frankincense, Boswellia serrata gum resin extract, boswellic acids, salai guggal

Add to a formula

A gum resin extract from the Boswellia serrata tree standardized to total boswellic acids, used in joint-comfort formulas often alongside curcumin. A systematic review and meta-analysis of randomized trials concluded that boswellia extracts supported pain, stiffness, and function outcomes in people with osteoarthritis. The 65% standard is the traditional, cost-effective grade; AKBA-enriched extracts are a more concentrated alternative.

Research summary

Boswellic acids, particularly AKBA, inhibit 5-lipoxygenase and reduce leukotriene formation, which is associated with lower inflammatory signaling in joints.

Dosage

Daily amounts, of extract.

Lowest studiedTypical rangeHighest studiedUpper limit
300–500 mg

300 to 500 mg per day, usually split into two or three doses with food, since boswellic acids absorb better with fat. Trials in osteoarthritis typically ran eight to twelve weeks; some users notice improvement within a few weeks.

Standardization: 65% boswellic acids

Source material: gum resin extract

Forms of Boswellia

FormTypical doseElement %FormatsPrice
Boswellia Serrata Extract (65% Boswellic Acids)300–500 mgCapsule, Tablet, Softgel, Powdermid
Boswellia Serrata Extract (30% AKBA)100–250 mgCapsule, Tablet, Softgel, Powderhigh

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Resinous and bitter; can be sticky in powders. Capsules and tablets preferred.

Formulation notes

Frequently combined with curcumin, ginger, or collagen in joint products. Absorption improves with dietary fat.

Sources

  1. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. (Yu 2020)PubMed

Related ingredients